iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy?

Broad diversification and lower costs favor iShares, but Invesco's concentrated biotech bet delivered 47% returns in one year—at the cost of steeper drawdowns.

fool.com ·1d ago

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy? nasdaq.com

Read the original at fool.com →

iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy?

Also reported by 1 other outlet

More in Finance & Markets

Susquehanna latest to pick up larger office space in Hong Kong’s Central, sources say

American Healthcare REIT Executive Sells 2,000 Shares for $111,000

'I am the house now': Scott Bessent warns traders not to bet against his plan to bolster the Japanese yen

United Therapeutics at Cantor healthcare conference: fibrosis push widens

Brent oil passes US$100 on Mideast flare-up, stoking inflation fears

PACS Group CEO Jason Hulse Murray sells $2.2m in stock